LIMN Liminatus Pharma LLC: Prakiraan rega marang bathi

LIMN (Liminatus Pharma) - tandha merek perusahaan

Liminatus Pharma (LIMN) forward P/E ratio exhibits volatility due to intense patent battles within the CAR-T therapy sector, where the metric stands at 0.00. Growth is driven by the co-financing of solid tumor research with biolabs. Development relies on private investments and the search for partners among academic centers to conduct clinical trials.

liminatuspharma.com - Pangali mangsa ngarep rega marang bathi LIMN (periode 02.05.2025 - 16.11.2026)

Rincian metrik lan analitis perusahaan liminatuspharma.com (LIMN)

Analisis fundamental perusahaan:Liminatus Pharma Inc. LIMN
Produk mawa merek Liminatus Pharma

Liminatus Pharma (LIMN) development of targeted CAR-T therapies against the GCC antigen in immuno-oncology determines the potential of the business's future cash flows. The company's expected P/E ratio compares the current market value of shares with projected net income, allowing investors to use this chart to assess the fairness of the asset's valuation and avoid value traps when analyzing the prospects for treating solid tumors.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Janux Therapeutics Inc - Prakiraan rega marang bathi|Arcus Biosciences (RCUS) - Rasio prakiraan rega marang bathi|ZYME: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TNGX (Tango Therapeutics, Inc.)|IOVA: Pangali Forward P/E|IMTX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep xencor.com|Prakiraan rega marang bathi compasstherapeutics.com (CMPX)|Rega marang bathi mangsa ngarep Replimune Group Inc (REPL)|Prakiraan rega marang bathi Lyell Immunopharma Inc LYEL|Innate Pharma SA - Prakiraan rega marang bathi|Pangali Forward P/E Pyxis Oncology, Inc. PYXS|CGEN - Rega marang bathi mangsa ngarep|IOBT (iobiotech.com) - Rasio rega marang bathi mangsa ngarep|Sutro Biopharma, Inc (STRO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MiNK (INKT)|Prakiraan rega marang bathi HOWL|IMMX - Pangali forward rega marang bathi|Prakiraan rega marang bathi ALXO (ALX Oncology Holdings)|CUE (Cue Biopharma) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PDSB (PDS Biotechnology)|Pangali mangsa ngarep rega marang bathi SONN|MAIABiotech.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi LAVA Therapeutics|NextCure, Inc. (NXTC) - Rega marang bathi mangsa ngarep|Leap Therapeutics Inc - Pangali mangsa ngarep rega marang bathi|INTS (Intensity Tx) - Pangali Forward P/E|Pangali Forward P/E senseibio.com|Rega marang bathi mangsa ngarep Theriva Biologics (TOVX)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E